When the traditional clinical trial format meets AI, magic happens. This was obvious listening to the expert panel discussing how AI is enhancing clinical trials today and the potential for future.
From identifying potential subjects through rapid and more complex data mining, using digital twins, to real time patient tracking that does not burden the clinician with mundane tasks, the opportunities are endless.
What also stood out in the conversation were the universal "Janitorial" data challenges that impact all healthcare and life science projects trying to use data in AI models, across the Payer, Provider Pharma/Biotech continuum:
Bad data/ heterogeneity of data/ old data
Biases in data
Lack of understanding and appreciation of "data flows" in the system, which truly derail projects
Inadequate investments in the non-glamorous but crucial "data foundation"
More interesting, these issues are not new ones. They have existed before this age of AI. Remember the days of receiving multi year worth of clinical trial data on a 18-tabbed excel sheet? the "blank cells" which could mean either missing data or "N/A"? and if you also had omic data, well.... the sample IDs differing by one alphabet could tailspin you down a few hours!!
Yes, those annoying, "low value" tasks, which have magnified their impact in the age of big-data.
As we look forward to using AI to it's fullest, we also need to really appreciate the importance of expert/SME curated, solid data foundations.
This will likely require some new and unusual partnerships too!
The future is bright, and road is bumpy. And if we can send man to moon, make aids history, we can solve the data challenges too!
#precisionmedicine #AI
Eine neue Zeit bringt neue Fragen hervor und braucht neue Wege. LIFE IS A JOURNEY, NOT A COMPETITON.
10moSonja Mannhardt, Evidenz in AI